IPIX to present in Florida at the MHSRS: WarFighter Medical Readiness at the MHSRS
Innovation Pharma to present during this session Day 1:
Development of New Front Line Therapies to Prevent and Treat non SARS CoV-2 Endemic Viral Diseases Infectious Disease Prevention and Treatment Abstracts should address: 1. Describe agnostic vaccine platforms to prevent non SARS-CoV-2 viral diseases; 2. New treatment approaches for non SARS-CoV-2 viral diseases; 3. Mitigation strategies to prevent spread /exposure to non SARS-CoV-2 viral diseases
Abstracts to be provide here:
SARS CoV-2 Research Update -- Abstracts should address on-going research related to the following research areas for SARS CoV-2: Prevention, Detection, Treatment, Enabling Technologies
Hope to have good news on trials prior to the MHSRS meeting in Florida
GLTA
BRILACIDIN *426* THE SAFE COVID KILLER
RBL TESTED AND APPROVED AGAINST COVID19